Pain at One Year Post-MI Linked to Increased Risk for Mortality
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 17, 2023 -- Pain is prevalent one year after myocardial infarction (MI) and is associated with an increased risk for all-cause mortality, according to a study published online Aug. 16 in the Journal of the American Heart Association.
Linda Vixner, P.T., Ph.D., from the School of Health and Welfare at Dalarna University in Falun, Sweden, and colleagues collected data from 18,376 patients aged younger than 75 years with a registered MI event during 2004 to 2013. In secondary prevention clinics, self-reported levels of experienced pain were recorded at one year after hospital discharge. All-cause mortality data were collected up to 8.5 years after the one-year visit.
The researchers found that 38.2 and 4.5 percent of included patients reported moderate and extreme pain, respectively. A total of 1,067 deaths occurred in the cohort. For moderate and extreme pain, the adjusted hazard ratios were 1.35 and 2.06, respectively. Compared with smoking, pain was a stronger predictor of mortality.
"Clinicians managing patients after MI should recognize the need to consider experienced pain as a prognostic factor comparable to persistent smoking, and to address this when designing individually adjusted cardiac rehabilitation and secondary prevention treatments," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Women, Black and Hispanic Adults Have Lower Angiography/PCI Use in NSTEMI
THURSDAY, May 16, 2024 -- Disparities are evident in the interventional management of non-ST-segment elevated myocardial infarction (NSTEMI) and in STEMI incidence and mortality...
Self-Administered Acupressure Reduces Knee Pain With Suspected Osteoarthritis
WEDNESDAY, April 24, 2024 -- Self-administered acupressure (SAA) is an efficacious and cost-effective approach to relieve knee pain in middle-aged and older adults with probable...
ACC: Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI
WEDNESDAY, April 10, 2024 -- Empagliflozin does not reduce the risk for first hospitalization for heart failure or death among patients at increased risk for heart failure after...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.